Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2012-04-11 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LONS (64140), Pyrenees-Atlantiques
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SARL PHARMACIE DU PERLIC : revenue, balance sheet and financial ratios
SARL PHARMACIE DU PERLIC is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LONS (64140),
this company of category PME
shows in 2022 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SARL PHARMACIE DU PERLIC (SIREN 750883480)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 598 161 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
60 541 €
78 381 €
98 137 €
98 090 €
54 223 €
87 059 €
73 757 €
107 219 €
69 757 €
EBITDA
N/C
N/C
136 699 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.1%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SARL PHARMACIE DU PERLIC generates positive net income of 61 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 70 k€ -> 61 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
60 541 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 135%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
134.59%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
35.718%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SARL PHARMACIE DU PERLIC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
1016.267
461.57
327.313
221.76
181.834
123.876
115.683
105.842
134.59
Financial autonomy
7.935
15.37
20.983
27.703
31.34
38.905
40.353
41.325
35.718
Repayment capacity
None
None
None
None
None
None
7.566
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
5.577%
None%
None%
Sector positioning
Debt ratio
134.592024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+10 pts over 3 years
In 2024, the debt ratio of SARL PHARMACIE DU PERLIC (134.59) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
35.72%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average-8 pts over 3 years
In 2024, the financial autonomy of SARL PHARMACIE DU PERLIC (35.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
7.57 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SARL PHARMACIE DU PERLIC (7.57) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 127.63. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
127.631
Liquidity indicators evolution SARL PHARMACIE DU PERLIC
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
107.374
109.578
127.708
110.796
109.521
92.304
134.757
108.422
127.631
Interest coverage
None
None
None
None
None
None
10.598
None
None
Sector positioning
Liquidity ratio
127.632024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch
In 2024, the liquidity ratio of SARL PHARMACIE DU PERLIC (127.63) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
10.6x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent
In 2022, the interest coverage of SARL PHARMACIE DU PERLIC (10.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 149 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 868 days. Excellent situation: suppliers finance 719 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
149 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
868 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SARL PHARMACIE DU PERLIC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
89 865 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
23
0
0
Customer payment term (days)
0
0
0
0
0
0
3
0
149
Supplier payment term (days)
0
0
0
0
0
0
48
0
868
Positioning of SARL PHARMACIE DU PERLIC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SARL PHARMACIE DU PERLIC is estimated at
845 197 €
(range 588 581€ - 1 264 463€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
588k€845k€1264k€
845 197 €Range: 588 581€ - 1 264 463€
NAF 5 année 2024
Valuation method used
Net Income Multiple
60 541 €
×
14.0x
=845 197 €
Range: 588 582€ - 1 264 463€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SARL PHARMACIE DU PERLIC with other companies in the same sector:
Frequently asked questions about SARL PHARMACIE DU PERLIC
What is the revenue of SARL PHARMACIE DU PERLIC ?
The revenue of SARL PHARMACIE DU PERLIC in 2022 is 1.6 M€.
Is SARL PHARMACIE DU PERLIC profitable?
Yes, SARL PHARMACIE DU PERLIC generated a net profit of 61 k€ in 2024.
Where is the headquarters of SARL PHARMACIE DU PERLIC ?
The headquarters of SARL PHARMACIE DU PERLIC is located in LONS (64140), in the department Pyrenees-Atlantiques.
Where to find the tax return of SARL PHARMACIE DU PERLIC ?
The tax return of SARL PHARMACIE DU PERLIC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SARL PHARMACIE DU PERLIC operate?
SARL PHARMACIE DU PERLIC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart